RETAKLIK 2.0

Purity

99.2%

Mol. Weight

Combo

Form

Prefilled Klik-Pen

Amino Acid Sequence

Retatrutide + Cagrilintide

RETAKLIK 2.0 is an advanced combination pen containing Retatrutide (30mg) and Cagrilintide (5mg) in 2.4ml solution. This combination targets four distinct metabolic receptors: GIP, GLP-1, Glucagon (via retatrutide), and Amylin (via cagrilintide). The quad-receptor approach represents the cutting edge of metabolic research, potentially offering additive effects on appetite suppression, energy expenditure, and glucose homeostasis beyond triple agonism alone.

Available Variants

SKU	Dosage	Price (AED)	Status
R20-1PEN	35mg	AED 995	AVAILABLE
R20-3PK	3x35mg	AED 2,685	AVAILABLE

Research Use Only. All products listed on this platform are intended solely for in-vitro research and laboratory use. They are not intended for human or animal consumption, medical diagnosis, or therapeutic application. By accessing this site, you confirm you are a qualified researcher or authorized procurement agent. No statements have been evaluated by any regulatory authority. Purchasers assume all responsibility for compliance with applicable local, national, and international regulations.